InsiderTrades

Form 4 for TNDM TANDEM DIABETES CARE INC

Accepted 2021-08-10 00:00:00 ET · period of report 2021-08-06 · accession 0001438133-21-000127 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2021-08-10 2021-08-06+ TNDM Sheridan John F Pres, CEO, Dir M - OptEx $17.03 +14.9K 15.8K +1,708% +$254.2K
DM 2021-08-10 2021-08-06+ TNDM Sheridan John F Pres, CEO, Dir S - Sale+OE $108.04 -14.9K 8,997 -62% -$1.61M
DM 2021-08-10 2021-08-06+ TNDM Sheridan John F Pres, CEO, Dir M - OptEx $17.03 +14.9K 0 New +$254.2K

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2021-08-06 M A 746 $11.06 6,943 D — —
2 Common Common Stock 2021-08-06 M A 2,180 $9.00 9,123 D — —
3 Common Common Stock 2021-08-06 M A 2,397 $18.86 11,520 D — —
4 Common Common Stock 2021-08-09 S D 1,872 $108.29 6,197 D — — (F5) The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $107.97 to $108.65. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.
5 Common Common Stock 2021-08-06 S D 2,800 $109.39 6,197 D — — (F3) The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $109.01 to $109.71. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.
6 Common Common Stock 2021-08-09 M A 9,603 $18.86 15,800 D — —
7 Common Common Stock 2021-08-09 S D 7,731 $107.49 8,069 D — — (F4) The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $106.96 to $107.93. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.
8 Common Common Stock 2021-08-06 S D 2,523 $108.03 8,997 D — — (F2) The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $108.00 to $108.13. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.
9 Derivative Stock Option 2021-08-09 M A 9,603 $18.86 63,000 D $18.86 · — to — 9,603 Common Stock (F9) The option vested as to fifty percent (50%) of the underlying shares on 06/14/2019, and the remaining shares vested in twelve (12) equal monthly installments thereafter. (F7) The expiration date for these options is 10 years from the date of grant.
10 Derivative Stock Option 2021-08-06 M A 2,397 $18.86 72,603 D $18.86 · — to — 2,397 Common Stock (F9) The option vested as to fifty percent (50%) of the underlying shares on 06/14/2019, and the remaining shares vested in twelve (12) equal monthly installments thereafter. (F7) The expiration date for these options is 10 years from the date of grant.
11 Derivative Stock Option 2021-08-06 M A 746 $11.06 0 D $11.06 · — to — 746 Common Stock (F6) The option vested as to One Hundred percent (100%) of the underlying shares on 04/23/2017. (F7) The expiration date for these options is 10 years from the date of grant.
12 Derivative Stock Option 2021-08-06 M A 2,180 $9.00 0 D $9.00 · — to — 2,180 Common Stock (F8) The option vested as to twenty-five percent (25%) of the underlying shares on 05/17/2018, and the remaining shares vested in thirty-six (36) equal monthly installments thereafter. (F7) The expiration date for these options is 10 years from the date of grant.